Literature DB >> 32023048

Size-Transformable Hyaluronan Stacked Self-Assembling Peptide Nanoparticles for Improved Transcellular Tumor Penetration and Photo-Chemo Combination Therapy.

Zhaoqing Cong1,2, Lu Zhang2, Si-Qi Ma1, Kit S Lam2, Fei-Fei Yang1, Yong-Hong Liao1.   

Abstract

Size-transformable nanomedicine has the potential to overcome systemic and local barriers, leading to efficient accumulation and penetration throughout the tumor tissue. However, the design of this type of nanomedicine was seldom based on active targeting and intracellular size transformation. Here, we report an intracellular size-transformable nanosystem, in which small and positively charged nanoparticles (<30 nm) prepared from the self-assembly of an amphiphilic hexadecapeptide derivative was coated by folic acid- and dopamine-decorated hyaluronan (HA) to form large and negatively charged nanoparticles (∼130 nm). This nanosystem has been proven to improve the blood circulation half-life of the drug and prevent premature intravascular drug leakage from the nanocarrier. Once accumulated in the tumor, the nanoparticles were prone to HA- and folic acid-mediated cellular uptake, followed by intracellular size transformation and discharge of transformed small nanoparticles. The size-transformable nanosystem facilitated the transcytosis-mediated tumor penetration and improved the internalization of nanoparticles by cells and the intracellular release of 7-ethyl-10 hydroxycamptothecin. With an indocyanine green derivative as the intrinsic component of the amphiphilic polymer, the nanosystem has exhibited additional theranostic functions: photoacoustic imaging, NIR-laser-induced drug release, and synergistic chemotherapy and phototherapy, leading to a 50% complete cure rate in a subcutaneous B16 melanoma model. This nanosystem with multimodalities and efficient tumor penetration has shown potentials in improving anticancer efficacy.

Entities:  

Keywords:  combination therapy; peptide nanoparticle; transcellular; transformable; tumor penetration

Year:  2020        PMID: 32023048     DOI: 10.1021/acsnano.9b08434

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  10 in total

1.  A multicomponent-based microemulsion for boosting ovarian cancer therapy through dual modification with transferrin and SA-R6H4.

Authors:  Haijun Zhao; Mengyuan Chen; Zhujiang Zhao; Linjia Zhu; Shaofei Yuan
Journal:  Drug Deliv Transl Res       Date:  2020-10-02       Impact factor: 4.617

Review 2.  Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment.

Authors:  Fei Qu; Rui Geng; Yijing Liu; Jintao Zhu
Journal:  Theranostics       Date:  2022-04-11       Impact factor: 11.600

Review 3.  Syntheses of Polypeptides and Their Biomedical Application for Anti-Tumor Drug Delivery.

Authors:  Huayang Feng; Jonas Fabrizi; Jingguo Li; Christian Mayer
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

4.  pH-responsive hybrid platelet membrane-coated nanobomb with deep tumor penetration ability and enhanced cancer thermal/chemodynamic therapy.

Authors:  Huang Yang; Yuan Ding; Zongrui Tong; Xiaohui Qian; Hao Xu; Fenghao Lin; Guoping Sheng; Liangjie Hong; Weilin Wang; Zhengwei Mao
Journal:  Theranostics       Date:  2022-05-16       Impact factor: 11.600

5.  What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity.

Authors:  Chanda Bhandari; Mina Guirguis; N Anna Savan; Navadeep Shrivastava; Sabrina Oliveira; Tayyaba Hasan; Girgis Obaid
Journal:  Nano Today       Date:  2020-12-16       Impact factor: 20.722

Review 6.  Recent Developments in Pathological pH-Responsive Polymeric Nanobiosensors for Cancer Theranostics.

Authors:  E K Pramod Kumar; Wooram Um; Jae Hyung Park
Journal:  Front Bioeng Biotechnol       Date:  2020-11-19

Review 7.  Turning cold tumors into hot tumors by improving T-cell infiltration.

Authors:  Yuan-Tong Liu; Zhi-Jun Sun
Journal:  Theranostics       Date:  2021-03-11       Impact factor: 11.556

8.  A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses.

Authors:  Xuan Wang; Yingqi Liu; Chencheng Xue; Yan Hu; Yuanyuan Zhao; Kaiyong Cai; Menghuan Li; Zhong Luo
Journal:  Nat Commun       Date:  2022-09-28       Impact factor: 17.694

9.  Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncRNA CCAT1 silencing and curcumin delivery for synchronous colorectal cancer theranostics.

Authors:  Fan Jia; Yunhao Li; Xiongwei Deng; Xuan Wang; Xinyue Cui; Jianqing Lu; Zian Pan; Yan Wu
Journal:  J Nanobiotechnology       Date:  2021-08-11       Impact factor: 10.435

10.  Experimental anti-tumor effect of emodin in suspension - in situ hydrogels formed with self-assembling peptide.

Authors:  Weipeng Wei; Jianhua Tang; Lei Hu; Yujie Feng; Hongfang Li; Chengchen Yin; Fushan Tang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.